TANDEM DIABETES CARE INC Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2013 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Tandem Diabetes Care Inc quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2013 to Q4 2023.
  • Tandem Diabetes Care Inc Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $191M, a 17.2% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $191M +$27.9M +17.2% Dec 31, 2023 10-K 2024-02-21
Q4 2022 $163M +$16.3M +11.1% Dec 31, 2022 10-K 2024-02-21
Q4 2021 $146M +$24.8M +20.4% Dec 31, 2021 10-K 2023-02-22
Q4 2020 $122M +$12M +11% Dec 31, 2020 10-K 2022-02-22
Q4 2019 $110M -$13.9M -11.3% Dec 31, 2019 10-K 2021-02-24
Q4 2018 $124M +$12.8M +11.6% Dec 31, 2018 10-K 2020-02-24
Q4 2017 $111M -$26.6M -19.4% Dec 31, 2017 10-K 2019-02-26
Q4 2016 $137M +$29.3M +27.2% Dec 31, 2016 10-K 2018-03-01
Q4 2015 $108M +$14.8M +15.8% Dec 31, 2015 10-K 2017-03-08
Q4 2014 $93.2M +$29.4M +46% Dec 31, 2014 10-K 2016-02-24
Q4 2013 $63.8M Dec 31, 2013 10-K 2015-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.